Increased neoplasm development due to immunosuppressive treatment with FK-506 in BALB/C mice persistently infected with the mouse herpesvirus (MHV- 72)

Viral Immunology

Volumn 12, Issue 3, 1999, Pages 237-247

  Mistríková, Jela ^a   Mrmusová, Miroslava ^a   Ďurmanová, Vladimíra ^b   Rajčàni, Július ^b  

^a Physics and Informatics   (Slovakia)

^b INSTITUTE OF VIROLOGY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HERPES VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NEOPLASM; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA; DNA VIRUSES; HERPES; HERPESVIRIDAE; MURINE HEPATITIS VIRUS; MURINE HERPESVIRUS 72;

EID: 0032846039     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1999.12.237     Document Type: Article

References (36)

1. Ambinder, R.F., and R.B. Mann. 1994. Detection and characterization of Epstein-Barr virus in clinical specimens. Am. J. Pathol. 145:2:139-152.
2. Blaškovič, D., M. Stančeková, J. Svobodová, and J. Mistríková. 1980. Isolation of five strains of herpesviruses from two species of free living small rodents. Acta. Virol 24:468-474.
3. Blaškovič, D., D. Staneková, J. Rajčáni. 1984. Experimental pathogenesis of murine herpesvirus in newborn mice. Acta. Virol. 28:225-231.
4. Cardin, R.D., Ch.L. Hardy, H.M. Hamilton-Easton, J.W. Brooks, M.A. Blackman, and P.C. Doherty. 1998. Characterization of the infectious mononucleosis-like syndrome induced by murine gammaherpesvirus-68. 23rd International Herpesvirus Workshop, York, p. 346.
5. Crawford, D.H. 1982. Epstein-Barr virus nuclear antigen positive lymphoma after cyclosporin: A treatment in a patient with renal allograft. Lancet. 1355-1356.
6. Culling, C.F.A., and W.T. Allison, R.T. Barr. Cellular Pathology Technique, IVth ed., Butterworth & Co. Ltd, London, 1985, pp. 642.
7. Dutia, B.M., R.A.E. Clayton, H. Dyson, and T. Nash. 1998. Cellular events following in vitro infection with murine gammaherpesvirus 68 (MHV 68). 23rd International Herpesvirus Workshop, York, p. 351.
8. Efstathiou S, Y.M. Ho, and A.C. Minson. 1990a. Cloning and molecular characterization of murine herpesvirus 68 genome. J. Gen. Virol. 71:1355-1364.
9. Efstathiou S., Y.M. Ho, S. Hall, C.J. Styles, S.D. Scott, and U.A. Compels. 1990b. Murine herpesvirus 68 is geneticaly related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. J. Gen. Virol. 71:1365-1372.
10. Graham, R.C., and M.J. Karnovsky. 1966. The early stages of absorbtion of injected horseradish peroxidase in the proximal tubules of the mouse kidney. Ultrastructural cytochemistry by a new technique. J. Histochem. Cytochem. 14:291-302.
11. Griffits, P.D. 1995. Herpesvirus disease in the immunocompromised host. 20th International Herpesvirus Workshop, Amsterdam, p. 16.
12. Hanto, D.W. 1981. Clinical spectrum of lymphoprolipherative disorders in renal recipients and evidence for the role of Epstein-Barr virus. Cancer. Res. 41:4253-4261.
13. Honbo, T., M. Kobayashi, K. Hane, T. Hata, and Y. Ueda. 1987. The oral dosage form of FK 506. Transplant. Proc. XIX, 5-6, 17-22.
14. Imai, S. 1990. Virological and immunological studies on inapparent Epstein-Barr virus infection in healthy individuals in comparison to immunosuppressed patients and patients with infectious mononucleosis. Hokkaido-Igaku-Yasshi. 65:5:481-492.
15. Kino, T., H. Hatanaka, M. Hashimoto, M. Nishiyama, T. Goto, M. Okuhara, M. Kohsaka, and M. Aoki. 1987a. FK 506, a novel immunosuppressant isolated from Streptomyces. J. Antibiot. 140:1249-1251.
16. Lee, S.E., J. Locker, M. Nalesnik, J. Reyes, R. Jaffe, M. Alashari, B. Nour, A. Tzakis, and P.S. Dickman. 1995. The association of Epstein-Barr virus with smooth-muscle tumors occuring after organ transplantation. N. Engl. J. Med. 332:19-25.
17. McDonald, G.A., J. Paul, B. Cruickshank. 1988. Atlas of Haemathology. Fifth ed. Churchill Livingstone, Edinburgh, London, Melbourne and New York, pp. 278.
18. Mistríková, J., and D. Blǎskovič. 1985. Ecology of murine Alphaherpesvirus and its isolation from lungs of rodents in cell culture. Acta. Virol. 29:312-317.
19. Mistríková, J., A. Remeňová, J. Leššo, and M. Stančeková. 1994. Replication and persistence of murine herpesvirus 72 in the lymphatic system and in peripheral blood mononuclear cells of Balb/c mice. Acta. Virol. 38:151-156.
20. Mistríková, J., J. Rajčáni, M. Mrmusová, and I. Oravcová. 1996b. Chronic infection of Balb/c mice with murine herpesvirus 72 is associated with neoplasm development. Acta. Virol. 40:297-301.
21. Mistríková, J., M. Mrmusová. 1998. Detection of abnormal lymphocytes in the blood of Balb/c mice infected with murine gammaherpesvirus strain 72: The analogy with Epstein-Barr virus infection. Acta. Virol. 42:79-82.
22. Nalesnik, M. 1991. Lymphoprolipherative disease in organ transplant recipients. Springer Semin. Immunopathol. 13:199-216.
23. Niedobitek, G., L.S. Young. 1994. Epstein-Barr virus persistence and virus-associated tumours. Lancet 393:5:333-335.
24. Rajčáni, J., D. Blaškovič, J. Svobodová, F. Čiampor, D. Hučková, and D. Staneková. 1985. Pathogenesis of acute and persistent murine herpesvirus infection in mice. Acta. Virol. 29:51-60.
25. Rajčáni, J., F. Čiampor, A. Sabó. 1975. Experimental latent herpesvirus infection in rabbits, mice and hamster: Ultrastructure of the virus activation in explanted Gasseric ganglia. Acta. Virol. 19:19-28.
26. Rajčáni, J., F. Čiampor, A. Sabó, H. Líbiková, M. Rozenbergová. 1977. Activation of latent herpesvirus hominis in explants of rabbit trigeminal ganglia: The influence pf immune serum. Arch. Virol. 53:55-69.
27. Robertson, K.A., E.J. Usherwood, and A.A. Nash. 1998. Regression of murine gammaherpesvirus 98 positive B cell lymphoma is mediated by CD4 lymphocytes in nude mice. 23rd Herpesvirus Workshop, York, p. 347.
28. Schermer, S. 1954. Die Blutmorphologie der Laboratoriumstiere. Johan Ambrosius Barth/Verlag Leipzig, pp. 159.
29. Shiraki, M., S. Hajegana, Y. Yamamura, Y. Kurokawa, and K. Yamamoto. 1995. Effect of immunosuppressants FK 506 and cyclosporine in mice cytomegalovirus. 20th International Herpesvirus Workshop, Amstedam, p. 234.
30. Sunil-Chandra, N.P., S. Efstathiou, J. Arno, and A.A. Nash. 1992a. Virological and pathological features of mice infected with murine gammaherpesvirus 68. J. Gen. Virol. 73:2347-2356.
31. Sunil-Chandra, N.P., S. Efstathiou, and A.A. Nash. 1992b. Murine gammaherpesvirus 68 established a latent infection in mouse B lymphocytes in vivo. J. Gen. Virol. 73:3275-3279.
32. Sunil-Chandra, N.P., J. Arno, J. Fazakerley, and A.A. Nash. 1994. Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68. Am. J. Pathol. 145:818-826.
33. Svobodová, J., D. Blaškovič, J. Mistríková. 1982a. Growth characteristics of herpesviruses isolated from free living small rodents. Acta. Virol. 26:256-263.
34. Thomas, M.L. 1989. The leukocyte common antigen family. Ann. Rev. Immunol. 7:339-369.
35. Yamamoto, K., T. Mon, M. Nakahava, H. Ito, H. Okudaira, and T. Miyamoto. 1990. Experimental treatment of autoimmune MRL-Ipr/Ipr mice with immunosuppressive compound FK-506. Immunology. 69:222-227.
36. Yoshizava, K., K. Kiyoshava, S. Yamada, K. Furata, K. Yabu, K. Kitano, T. Akamatsu, J. Nakayama, T. Katsuyama, and H. Matsunami. 1993. Establishment of Epstein-Barr virus associated lymphoma cell line SVBL with t(2,3)(pLL,q27) from a liver transplan patient. Canc. Genet. Cytogenet. 71:2:155-163.